Sign in
4

Changes in Ownership

Definium Therapeutics, Inc. Filed Acc 0001104659-24-132160

Chief Legal Officer sold 4,519 shares at $7.43 ($33,576)

  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Sullivan Mark · Chief Legal Officer

Table I: Non-derivative

1 line
Date Transaction Shares Price Value Owned after D/I
2024-12-26 Sale : show line 1 in the form 10b5-1 −4,519 $7.43 $33,576 173,197 D
Open-market sales · 4,519 sh · avg $7.43 · $33,576
Loading xslF345X05/tm2432133-1_4seq1.xml…